| abstract |
Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (I): n n n n n n n n n n where m, n, p, V, R 1 , R 2 , R 3 , R 4 , R 5 and R 6 are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed. |